Evaluating the safety and potential activity of URO‐902 (hMaxi‐K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non‐neurogenic) overactive bladder syndrome and detrusor overactivity from two double‐blind, imbalanced, placebo‐controlled randomized phase 1 trials-Reference-Cited by-同舟云学术

Evaluating the safety and potential activity of URO‐902 (hMaxi‐K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non‐neurogenic) overactive bladder syndrome and detrusor overactivity from two double‐blind, imbalanced, placebo‐controlled randomized phase 1 trials

Published:2020-01-16 Issue:2 Volume:39 Page:744-753
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Rovner Eric¹^ORCID,Chai Toby C.²^ORCID,Jacobs Sharon³,Christ George⁴,Andersson Karl‐Erik⁵,Efros Mitchell⁶,Nitti Victor⁷,Davies Kelvin⁸,McCullough Andrew R.⁹,Melman Arnold⁸^ORCID

Affiliation:

1. Department of Urology Medical University of South Carolina Charleston South Carolina

2. Department of Urology Boston University School of Medicine Boston Massachusetts

3. Ion Channel Innovations, LLC New York New York

4. Department of Orthopaedics University of Virginia Medical School Charlottesville Virginia

5. Department of Urology Wake Forest School of Medicine Winston‐Salem North Carolina

6. Accumed Research Associates Garden City New York

7. Departments of Urology and Obstetrics and Gynecology David Geffen School of Medicine at UCLA Los Angeles California

8. Department of Urology Albert Einstein College of Medicine New York New York

9. Department of Urology Tufts University School of Medicine Boston Massachusetts

Funder

Ion-03 National Institute of Aging

Ion Channel Innovations, LLC

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24272

Reference25 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society

2. Mechanisms of disease: central nervous system involvement in overactive bladder syndrome;Andersson KE;NatClinPract Urol.,2004

3. Pharmacological Management of Women with Mixed Urinary Incontinence

4. The “Costs” of Urinary Incontinence for Women

5. Prevalence and burden of overactive bladder in the United States

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and opportunities in intravesical drug delivery approaches for the treatment of lower urinary diseases;Journal of Drug Delivery Science and Technology;2024-10

2. Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome;International Journal of Molecular Sciences;2024-07-23

3. Emerging therapies for overactive bladder: preclinical, phase I and phase II studies;Expert Opinion on Investigational Drugs;2024-05-09

4. Promising therapeutic targets for the treatment of urine storage dysfunction: what’s the status?;Expert Opinion on Therapeutic Targets;2024-04-02

5. Gene Therapy and Overactive Bladder;Current Bladder Dysfunction Reports;2024-01-15